Bodal Chemicals Ltd Q4 FY25 Results & Concall Highlights: Revenue, Margins & Order Book

Q4 FY25 earnings call analysis: revenue, margin, capex, fundraise and order book outlook from management commentary.

Published 25 May 2026 | Chemicals & Petrochemicals | Market Cap: ₹950 Cr

FY'26 revenue is targeted at Rs. FY'26 top-line expected around Rs.

From Bodal Chemicals Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Price

₹79

Market Cap

₹950 Cr

P/E Ratio

13.8

How does Bodal Chemicals Ltd rank in Chemicals & Petrochemicals?

Compare Bodal Chemicals Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Bodal Chemicals Ltd — Quarterly revenue & net profit

Revenue Net Profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹588 Cr, net profit ₹32 Cr.

Full financials →

📊 Revenue & Sales Performance

→FY'26 revenue is targeted at Rs. 1,900 crores plus, representing about 10% growth over FY'25.
→EBITDA margins expected at 11%-12% in FY'26, improving from FY'25 Q4 levels.
→Dye intermediate volumes to remain flat in FY'26 and FY'27, having achieved over 70% utilization.
→Dyestuff volumes projected to grow 10%-15% in FY'26 supported by better end-user demand.
→Benzene derivatives segment aims to increase utilization from ~30% to 60%-70% in FY'26, targeting 80% long-term.
→Caustic soda division expects 5%-10% volume growth in FY'26 with strong margins.
→Basic chemicals volume and revenue expected to remain stable, similar to FY'25.
→Subsidy inflows (approx. Rs. 40 crore in FY'26, Rs. 24 crore annually thereafter) to support cash flows.
→Long-term growth plan includes potential large CAPEX post FY'27 after stabilizing businesses and reducing debt.

📈 Profitability & Margins

- FY'26 top-line expected around Rs. 1,900 - 2,000 crores, approx. 10% growth from FY'25. - EBITDA margin targeted at 11%-12%, improving from Q4 FY'25's ~11%. - Benzenes derivatives utilization to increase to 60%-65% in FY'26, aiming for 80% optimum utilization later, improving margins. - Dyestuff business expected to grow ~10%-15% in volume in FY'26; dye intermediates expected to remain stable. - Stable or slightly better performance anticipated from caustic soda and Chlor-Alkali divisions. - Subsidies from Punjab (~Rs. 20 crore/year) and Gujarat (~Rs. 4 crore/year) projected to support cash flows over next 7 years. - Debt reduction planned (~Rs. 120-150 crore repayment in current year), lowering interest costs and improving profitability. - Longer-term (~FY'27 onwards), potential for CAPEX for further expansion after stabilizing current businesses and improving utilization. Overall, a gradual growth in earnings/profits with margin improvement and volume growth in key segments is expected in the near term.

See what Bodal Chemicals Ltd said on profitability & margins — free account, 30 seconds.

🏗️ Capital Expenditure Plans

→No major CAPEX planned for FY'26; focus is on increasing utilization and reducing losses (especially in benzene derivatives).
→Small expansion possible at Rajpura caustic chlorine unit with low CAPEX, planned anytime as a brownfield project.
→Large-sized investments or expansions likely from FY'27 onwards or later, after improving debt-equity ratios and stabilizing businesses.
→FY'27 could see sizable CAPEX after achieving 15-20% growth and stabilizing newer opportunities.
→Long-term plan includes exploring larger CAPEX cycles but not in the current year.
→Focus for the near term is on ramping up utilization (benzene derivatives to 80%), improving margins, and reducing debt before large investments.

💰 Fundraising & Capital Structure

→No major new capital expenditure (CAPEX) or large fundraising through debt or equity is planned for FY'26; the focus is on stabilizing current operations and reducing long-term debt.
→Some small expansion within existing plants (e.g., caustic chlorine unit) is possible but involves low CAPEX.
→Debt reduction is a priority, with planned repayment of Rs. 120-150 crore in the current year through scheduled repayment and asset sales.
→Large CAPEX or fundraising may be considered beyond FY'26, possibly starting FY'27 or later, once utilization levels improve and debt is reduced.
→Any future investments will depend on achieving better debt-to-equity ratios and overall financial health before pursuing new fundraising.

See what Bodal Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.

📋 Order Book & Pipeline

The transcript from Bodal Chemicals Limited's Q4 & FY'25 Earnings Call does not explicitly mention details about the company's current or expected orderbook or pending orders. There is no direct reference to order backlog figures or order pipeline status in the provided pages of the call transcript. The discussion primarily focuses on: - Operational performance across different product segments. - Volume utilization and capacity utilization plans for various chemical products. - Business outlook and growth expectations (e.g., aiming for utilization increases, anticipated growth in dyestuff volumes, stability in intermediate volumes). - Impact of regulatory developments such as anti-dumping duties. - Financial results, debt reduction plans, and capacity expansions. For specific orderbook or pending orders data, Bodal Chemicals might disclose that information in other investor communications or official filings beyond this transcript.

Key Metrics

How does Bodal Chemicals Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1Bodal Chemicals Ltd

See full Chemicals & Petrochemicals sector rankings

What Bodal Chemicals Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

CLEAN (Q4 FY25)
2,500 crores to Rs. Key concall takeaways from Clean Science's Q4 FY25 earnings call — and how it ranks against sector peers.
YASHO (Q4 FY25)
Exports continue to be a key revenue driver, contributing around 67% of total revenue. Key concall takeaways from Yasho Industries's Q4 FY25 earnings call…
Vinati Organics Ltd (Q4 FY25)
Overall growth supported by strategic capex (~INR360 crores in FY26), innovation, and operational efficiencies. Key concall takeaways from Vinati Organics's Q4…
PCBL (Q4 FY25)
Export sales volume for Carbon Black grew strongly by 16.8% in Q4 FY'25, reflecting strong international demand. Key concall takeaways from PCBL Chemical's Q4…

Compare:vs Solar Industries India Ltd vs PIDILITIND vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Bodal Chemicals Ltd Q4 FY25 results?

FY'26 revenue is targeted at Rs. FY'26 top-line expected around Rs.

What is Bodal Chemicals Ltd share price analysis?

Bodal Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 13.8 with a market cap of ₹950 Cr. Investors should review the full earnings analysis for detailed insights.

Is Bodal Chemicals Ltd planning capital expenditure?

No major CAPEX planned for FY'26; focus is on increasing utilization and reducing losses (especially in benzene derivatives).

Keep Bodal Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.